These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35070423)

  • 1. High expression of Ran binding protein 1 predicts poor outcomes in hepatocellular carcinoma patients: a Cancer Genome Atlas database analysis.
    Wei Z; Duan X; Li Q; Li Q; Wang Y
    J Gastrointest Oncol; 2021 Dec; 12(6):2966-2984. PubMed ID: 35070423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma.
    Qin Z; Xie B; Qian J; Ma X; Zhang L; Wei J; Wang Z; Fan L; Zhu Z; Qian Z; Yin H; Zhu F; Tan Y
    Front Oncol; 2023; 13():1144269. PubMed ID: 37056349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma.
    Liu T; Li ZZ; Sun L; Yang K; Chen JM; Han XY; Qi LM; Zhou XG; Wang P
    BMC Cancer; 2023 Oct; 23(1):1007. PubMed ID: 37858061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of prognostic value and immunological roles of RAB22A in hepatocellular carcinoma.
    Wen F; Meng F; Li X; Li Q; Liu J; Zhang R; Zhao Y; Zhang Y; Wang X; Ju S; Cui Y; Lu Z
    Front Immunol; 2023; 14():1086342. PubMed ID: 36936971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of NOP58 as a Prognostic Marker in Hepatocellular Carcinoma: A TCGA Data-Based Analysis.
    Wang J; Huang R; Huang Y; Chen Y; Chen F
    Adv Ther; 2021 Jun; 38(6):3342-3361. PubMed ID: 34014550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma.
    Li TH; Qin C; Zhao BB; Cao HT; Yang XY; Wang YY; Li ZR; Zhou XT; Wang WB
    Front Oncol; 2021; 11():665192. PubMed ID: 34123827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of
    Yang P; Liu H; Li Y; Gao Q; Chen X; Chang J; Li Y; Chen S; Dong R; Wu H; Liu C; Liu G
    Front Genet; 2022; 13():959832. PubMed ID: 36299588
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic Biomarker DDOST and Its Correlation With Immune Infiltrates in Hepatocellular Carcinoma.
    Zhu C; Xiao H; Jiang X; Tong R; Guan J
    Front Genet; 2021; 12():819520. PubMed ID: 35173766
    [No Abstract]   [Full Text] [Related]  

  • 10. Elevated NDC1 expression predicts poor prognosis and correlates with immunity in hepatocellular carcinoma.
    Liu Q; Gu L; Qiu J; Qian J
    J Gastrointest Oncol; 2023 Feb; 14(1):245-264. PubMed ID: 36915467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RBM39 is a potential prognostic biomarker with functional significance in hepatocellular carcinoma.
    Cui F; Wang W; Zhuang C; He D; Wang P
    Transl Cancer Res; 2024 Apr; 13(4):1606-1622. PubMed ID: 38737697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
    Xu H; Xiong C; Chen Y; Zhang C; Bai D
    Bioengineered; 2021 Dec; 12(1):2664-2675. PubMed ID: 34115569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
    Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
    Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data.
    Zeng Z; Cao Z; Tang Y
    BMC Cancer; 2020 Oct; 20(1):1037. PubMed ID: 33115417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated CDK5R1 predicts worse prognosis in hepatocellular carcinoma based on TCGA data.
    Zeng Z; Cao Z; Zhang E; Huang H; Tang Y
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33346796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCDC25 may be a potential diagnostic and prognostic marker of hepatocellular carcinoma: Results from microarray analysis.
    Deng H; Zhang J; Zheng Y; Li J; Xiao Q; Wei F; Han W; Xu X; Zhang Y
    Front Surg; 2022; 9():878648. PubMed ID: 36211267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CELSR3 mRNA expression is increased in hepatocellular carcinoma and indicates poor prognosis.
    Gu X; Li H; Sha L; Mao Y; Shi C; Zhao W
    PeerJ; 2019; 7():e7816. PubMed ID: 31608178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DPF2 overexpression correlates with immune infiltration and dismal prognosis in hepatocellular carcinoma.
    Yang K; Nong J; Xie H; Wan Z; Zhou X; Liu J; Qin C; Luo J; Zhu G; Peng T
    J Cancer; 2024; 15(14):4668-4685. PubMed ID: 39006087
    [No Abstract]   [Full Text] [Related]  

  • 19. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
    Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
    Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
    [No Abstract]   [Full Text] [Related]  

  • 20. UHRF1 Could Be a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma.
    Li D; Chen B; Zeng Y; Wang H
    Int J Gen Med; 2021; 14():6769-6776. PubMed ID: 34675635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.